View in EDS HTML Full Text PDF Full Text

Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.

Saved in:
Bibliographic Details
Title: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.
Authors: Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. abataller@mdanderson.org., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Urrutia S; Division of Oncology, Washington University in St. Louis, St. Louis, MO, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bouligny IM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Swaminathan M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roboz GJ; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA., Savona M; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., McCloskey J; Hackensack University Medical Center, Hackensack, NJ, USA., Odenike O; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA., Oganesian A; Taiho Oncology, Inc., Princeton, NJ, USA., Keer HN; Taiho Oncology, Inc., Princeton, NJ, USA., Azab M; Taiho Oncology, Inc., Princeton, NJ, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Source: Blood cancer journal [Blood Cancer J] 2025 Mar 31; Vol. 15 (1), pp. 50. Date of Electronic Publication: 2025 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40164584
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bataller+A%22">Bataller A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. abataller@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Urrutia+S%22">Urrutia S</searchLink>; Division of Oncology, Washington University in St. Louis, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Montalban-Bravo+G%22">Montalban-Bravo G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bazinet+A%22">Bazinet A</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Chien+K%22">Chien K</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hammond+D%22">Hammond D</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bouligny+IM%22">Bouligny IM</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Swaminathan+M%22">Swaminathan M</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Issa+G%22">Issa G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Short+N%22">Short N</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Daver+N%22">Daver N</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kadia+T%22">Kadia T</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Jabbour+E%22">Jabbour E</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Roboz+GJ%22">Roboz GJ</searchLink>; Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Savona+M%22">Savona M</searchLink>; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Griffiths+EA%22">Griffiths EA</searchLink>; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22McCloskey+J%22">McCloskey J</searchLink>; Hackensack University Medical Center, Hackensack, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Odenike+O%22">Odenike O</searchLink>; The University of Chicago Pritzker School of Medicine, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Oganesian+A%22">Oganesian A</searchLink>; Taiho Oncology, Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Keer+HN%22">Keer HN</searchLink>; Taiho Oncology, Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Azab+M%22">Azab M</searchLink>; Taiho Oncology, Inc., Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Kantarjian+H%22">Kantarjian H</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Mar 31; Vol. 15 (1), pp. 50. <i>Date of Electronic Publication: </i>2025 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40164584
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-025-01245-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 50
    Titles:
      – TitleFull: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bataller A
      – PersonEntity:
          Name:
            NameFull: Sasaki K
      – PersonEntity:
          Name:
            NameFull: Urrutia S
      – PersonEntity:
          Name:
            NameFull: Montalban-Bravo G
      – PersonEntity:
          Name:
            NameFull: Bazinet A
      – PersonEntity:
          Name:
            NameFull: Chien K
      – PersonEntity:
          Name:
            NameFull: Hammond D
      – PersonEntity:
          Name:
            NameFull: Bouligny IM
      – PersonEntity:
          Name:
            NameFull: Swaminathan M
      – PersonEntity:
          Name:
            NameFull: Issa G
      – PersonEntity:
          Name:
            NameFull: Short N
      – PersonEntity:
          Name:
            NameFull: Daver N
      – PersonEntity:
          Name:
            NameFull: DiNardo CD
      – PersonEntity:
          Name:
            NameFull: Kadia T
      – PersonEntity:
          Name:
            NameFull: Jabbour E
      – PersonEntity:
          Name:
            NameFull: Ravandi F
      – PersonEntity:
          Name:
            NameFull: Roboz GJ
      – PersonEntity:
          Name:
            NameFull: Savona M
      – PersonEntity:
          Name:
            NameFull: Griffiths EA
      – PersonEntity:
          Name:
            NameFull: McCloskey J
      – PersonEntity:
          Name:
            NameFull: Odenike O
      – PersonEntity:
          Name:
            NameFull: Oganesian A
      – PersonEntity:
          Name:
            NameFull: Keer HN
      – PersonEntity:
          Name:
            NameFull: Azab M
      – PersonEntity:
          Name:
            NameFull: Kantarjian H
      – PersonEntity:
          Name:
            NameFull: Garcia-Manero G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 03
              Text: 2025 Mar 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1